Indications and uses
For the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun. May be used as a protectant against further irritation.
For the temporary relief of burning, irritation and discomfort due to dryness of the eye or exposure to wind or sun. May be used as a protectant against further irritation.
Instill 1 or 2 drops in the affected eye(s) as needed.
Drug Facts
Polyethylene Glycol 400 0.25%
Eye lubricant
You experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
Keep out of the reach of children.
If swallowed, get medical help of contact a Poison Control Center right away.
Instill 1 or 2 drops in the affected eye(s) as needed.
Use only if tape seals on top and bottom flaps are intact.
RETAIN THIS CARTON FOR FUTURE REFERENCE.
Boric acid, calcium chloride, magnesium chloride, potassium chloride, purified water, sodium borate, sodium chloride, sodium chlorite (OcuPure ®Brand) as a preservative; Sodium Hyaluronate.
In the U.S. call 1-800-347-5005
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1094102 | blink Tears 0.25 % Ophthalmic Solution | PSN | 11 |
| 853238 | polyethylene glycol 400 0.25 % Ophthalmic Solution | PSN | 11 |
| 1094102 | polyethylene glycol 400 2.5 MG/ML Ophthalmic Solution [Blink Tears] | SBD | 11 |
| 853238 | polyethylene glycol 400 2.5 MG/ML Ophthalmic Solution | SCD | 11 |
| 1094102 | Blink Tears 0.25 % Lubricating Eye Drops | SY | 11 |
| 1094102 | Blink Tears 2.5 MG/ML Ophthalmic Solution | SY | 11 |
| 853238 | PEG-400 0.25 % Ophthalmic Solution | SY | 11 |
| 853238 | polyethylene glycol 400 0.25 % Ophthalmic Solution | SY | 11 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 29943-004-02 | blink gel tears | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 11 | |
| 29943-004-02 | blink gel tears | 2 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 2 | 11 | |
| 29943-004-10 | blink gel tears | 10 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 10 | 11 | |
| 29943-004-10 | blink gel tears | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 11 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 29943-004-10 | ML - Milliliter | 29943-004 | 11f7dd06-e6d5-4ced-a3aa-8e06bac91081 | 1 | 2020-09-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Polyethylene Glycol 400 | ACTIVE INGREDIENT | B697894SGQ | 2 | |
| Polyethylene Glycol 400 | ACTIVE MOIETY | B697894SGQ | 2 | |
| Boric Acid | INACTIVE INGREDIENT | R57ZHV85D4 | 2 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 2 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 2 | |
| Magnesium Chloride | INACTIVE INGREDIENT | 02F3473H9O | 2 | |
| Potassium Chloride | INACTIVE INGREDIENT | 660YQ98I10 | 2 | |
| SODIUM BORATE | INACTIVE INGREDIENT | 91MBZ8H3QO | 2 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| SODIUM CHLORITE | INACTIVE INGREDIENT | G538EBV4VF | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 29943-004 | 29943-004-10, 29943-004-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BORIC ACID | R57ZHV85D4 | IACT |
| CALCIUM CHLORIDE | M4I0D6VV5M | IACT |
| MAGNESIUM CHLORIDE | 02F3473H9O | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM CHLORITE | G538EBV4VF | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| Calcium Chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| SODIUM CHLORITE | SODIUM CHLORITE | G538EBV4VF | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v | ||
| Potassium Chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| Magnesium Chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| SODIUM BORATE | SODIUM BORATE | 91MBZ8H3QO | SOLUTION/ DROPS / OPHTHALMIC | 1.1 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| blink gel tears | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 6f7e06c3-204d-459a-af8f-c46be9ad0e8d | 2024-09-20 | Warnings | 29943-004-02 29943-004-10 29943-004 29943000402 29943000410 2298ed48-73f6-01eb-e063-6294a90ae899 6f7e06c3-204d-459a-af8f-c46be9ad0e8d |
Adverse event summaries are temporarily unavailable. Other product information remains available.